Temasek Holdings
Temasek's portfolio reaches $235b in 2018
Temasek Holdings saw its net portfolio value reach S$308 billion ($235 billion) as the Singapore government-controlled investment fund stepped up its investment activity in the 12 months ended March 2018.
Temasek to invest $50m in TPG's Asia healthcare platform
Asia Healthcare Holdings (AHH), a healthcare-focused operating and investment platform managed by TPG Growth, has raised $50 million from Singapore’s Temasek Holdings.
Temasek, RRJ to take 49% stake in HNA-owned Gategroup
Temasek Holdings and RRJ Capital have invested an unspecified amount for a significant minority stake in Gategroup, an airline catering provider owned by troubled Chinese conglomerate HNA Group.
Cancer drug developer Innovent Biologics files for HK IPO
Innovent Biologics, a Chinese drug developer company with a number of PE backers, has filed for an IPO in Hong Kong under recently introduced rules allowing listings by biotech companies with no revenue or profits.
Singapore's CashShield gets $20m Series B
Temasek Holdings and GGV Capital have led a $20 million Series B funding round for CashShield, an online fraud management services company for mid to large sized enterprises based in Singapore.
China's Ant Financial closes $14b Series C round
Ant Financial, Alibaba Group’s financial services affiliate, has raised $14 billion in Series C funding from investors including GIC Private, Warburg Pincus, The Carlyle Group, Silver Lake, and Canada Pension Plan Investment Board (CPPIB).
Temasek launches $300m India logistics platform
Temasek Holdings has joined Ascendas-Singbridge, its real estate-focused joint venture with state-owned development firm JTC Corporation, to launch a INR20 billion ($300 million) investment program for Indian logistics and industrial assets.
Drug developer Just China raises $35m
Hangzhou Just Biotherapeutics (Just China), the Chinese joint venture of US drug developer Just Biotherapeutics, has received $35 million in Series B-plus funding led by Hillhouse Capital.
Temasek unit targets $500m PE fund-backed bond issue
Retail investors in Singapore will be able to get exposure to the Temasek Holdings private equity portfolio through a $500 million bond issuance backed by 36 funds, including vehicles managed by The Blackstone Group, KKR, Silver Lake Partners, and TPG...
Capital Group leads Series E for China's Innovent Biologics
Capital Group Private Markets (CGPM), a private equity affiliate of US-based Capital Group Companies, has led a $150 million Series E round for Chinese biopharmaceutical developer Innovent Biologics.
EV in Asia: Easy riders
Higher scooter and motorcycle use rates in Asia suggest an opening for the region to take the lead in clean mobility. Early investors in electric two-wheelers have outlined the opportunity
Alibaba leads $600m round for China's SenseTime
Alibaba Group has led a $600 million Series C round for China's SenseTime, said to be the largest-ever fundraise by an artificial intelligence (AI) company globally.
Singapore's Pavilion commits $50m to education fund
Pavilion Capital, a private equity unit of Singapore’s Temasek Holdings, has agreed to invest $50 million in an education fund that will support various country-specific preschool acquisition programs.
Temasek, Sailing lead $114m round for Impossible Foods
Singapore’s Temasek Holdings and China’s Sailing Capital have led a $114 million round for Impossible Foods, a US-based vegetarian food technology company currently expanding into Asia.
Temasek leads $250m round for China's Sunny Education
Sunny Education, a China-based K-12 online education platform which operates under the 17zuoye brand, has raised $250 million in a Series E round led by existing investor Temasek Holdings.
Deal focus: Shunwei backs scalable home design model
Kujiale raises $100 million in Series D funding to grow its China-focused online home design tool
China's JW Therapeutics gets $90m Series A round
JW Therapeutics, a China-based clinical stage biopharmaceutical company, has raised $90 million in a Series A round of funding led by Temasek Holdings, Sequoia Capital China, and Yuan Ming Capital.
Indonesia's Go-Jek secures $1.5b Series E round
Indonesian ride-hailing and delivery platform Go-Jek has closed its Series E round at $1.5 billion with contributions from the likes of Tencent Holdings, JD.com, Meituan-Dianping, Google, Temasek Holdings, BlackRock, and Samsung Venture Investment.
Singapore to launch $76m IP commercialization vehicle
Singapore will support local start-ups through a S$100 million ($76 million) intellectual property (IP) commercialization fund, with Temasek Holdings set to provide at least half the capital.
Indonesia's Go-Jek scales up with Series E round
Indonesian ride-hailing and delivery platform Go-Jek is set to achieve a post-deal valuation of more than $5 billion through a funding round that was expected to reach $1.5 billion but has seen the addition of several strategic backers.
Deal focus: Rokid attracts interest as household AI heats up
The Series C round for smart household device manufacturer Rokid underlines investor interest in China-based artificial intelligence plays
Temasek leads Series C for China home automation player
Singapore’s Temasek Holdings has led a Series C round of undisclosed size for Rokid, a Chinese artificial intelligence (AI) developer focused on home automation devices.
Temasek leads $80m round for Singapore biopharma player
Singapore’s Temasek Holdings has led an $80 million funding round for domestic biopharmaceutical company Tessa Therapeutics with support from a number of venture and growth capital investors.
Chinese travel platform Mafengwo secures $133m Series D
Chinese travel services platform Mafengwo has raised $133 million Series D round from new investors including Ocean Link, General Atlantic, Temasek Holdings, Yuantai Investment, and Hopu Investment.